Ectopic expression of MyD88L265P, but not of wild-type MyD88 in GCB DLBCL cell lines, which exhibit per se little to no NF-κB activity, potently induces NF-κB activation, demonstrating the oncogenic capacity of this MyD88 variant. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.